FineHeart appoints André-Jacques Auberton-Hervé Member of the Board of Directors
Bordeaux, France, September 24, 2024 – FineHeart S.A, a clinical-stage medtech company developing
breakthrough solutions for cardiology, is pleased to announce the appointment of André-Jacques
Auberton-Hervé to its Board of Directors.